Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-021-01031-8
Abstract: Beraprost sodium (BPS), an orally administrable prostaglandin I2 derivative, is used for the treatment of chronic arterial occlusion and pulmonary arterial hypertension and has potential efficacy in nephropathy. Beraprost sustained release (beraprost SR) is an…
read more here.
Keywords:
japanese chinese;
pharmacokinetic profiles;
chinese korean;
sustained release ... See more keywords